Dudley & Shanley Inc. Acquires 12,400 Shares of Avantor, Inc. (NYSE:AVTR)

Dudley & Shanley Inc. lifted its holdings in Avantor, Inc. (NYSE:AVTR) by 1.1% during the 1st quarter, HoldingsChannel.com reports. The firm owned 1,111,355 shares of the company’s stock after acquiring an additional 12,400 shares during the quarter. Avantor makes up about 4.8% of Dudley & Shanley Inc.’s portfolio, making the stock its 5th biggest holding. Dudley & Shanley Inc.’s holdings in Avantor were worth $28,417,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in AVTR. Mariner LLC increased its position in shares of Avantor by 17.3% in the third quarter. Mariner LLC now owns 42,025 shares of the company’s stock worth $886,000 after acquiring an additional 6,196 shares in the last quarter. Tower Research Capital LLC TRC increased its position in shares of Avantor by 170.4% in the third quarter. Tower Research Capital LLC TRC now owns 24,722 shares of the company’s stock worth $521,000 after acquiring an additional 15,580 shares in the last quarter. Bank of Nova Scotia increased its position in shares of Avantor by 18.1% in the third quarter. Bank of Nova Scotia now owns 16,024 shares of the company’s stock worth $338,000 after acquiring an additional 2,455 shares in the last quarter. Glenmede Trust Co. NA increased its position in shares of Avantor by 300.1% in the third quarter. Glenmede Trust Co. NA now owns 139,143 shares of the company’s stock worth $2,933,000 after acquiring an additional 104,362 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. purchased a new position in shares of Avantor in the third quarter worth approximately $16,864,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on AVTR shares. Barclays dropped their target price on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Friday, June 28th. Robert W. Baird decreased their price target on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, April 29th. Evercore ISI decreased their price target on shares of Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Avantor from $23.00 to $25.00 and gave the stock a “hold” rating in a report on Thursday, April 18th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $26.29.

Avantor Stock Performance

Shares of Avantor stock traded up $0.43 on Wednesday, reaching $21.01. The stock had a trading volume of 5,206,885 shares, compared to its average volume of 5,819,742. The business’s 50-day moving average price is $23.56 and its two-hundred day moving average price is $23.79. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. Avantor, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $26.16. The stock has a market cap of $14.27 billion, a P/E ratio of 53.87, a price-to-earnings-growth ratio of 2.15 and a beta of 1.32.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02. Avantor had a net margin of 3.79% and a return on equity of 13.01%. The business had revenue of $1.68 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same period in the previous year, the company earned $0.29 earnings per share. Avantor’s revenue for the quarter was down 5.6% on a year-over-year basis. On average, sell-side analysts forecast that Avantor, Inc. will post 1.01 EPS for the current year.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.